These include controlling subcellular localization of PTEN to promote AML progression, stabilization of the histone demethylase PHF8 to promote breast carcinogenesis, and stabilization of N‐Myc to promote neuroblastoma progression, among others.24, 25, 26. Here, MYCN is linked to acute myeloid leukemia.